English sottotitoli

← COVID-19: Moderna vaccine approved for use in Singapore

Ottieni il codice di inserimento
16 Lingue

Mostrare Revisione 3 creata 02/06/2021 da alex.111.

  1. The health sciences authority
  2. has approved the Moderna Covid-19 vaccine
  3. for use in Singapore.
  4. the first shipment is expected to arrive
  5. next month
  6. and will be progressively rolled out
  7. to those, aged 18 and above,
  8. Nisha Rahim with more:
  9. [Nisha Rahim] it's been over a month
  10. since Singapore received it's first
  11. Pfizer-BioNTech Covid-19 vaccine.
  12. shortly after, the country kick-started
  13. it's vaccination programme.
  14. on Wednesday, Singapore approved the use
  15. of the Moderna Covid-19 vaccine.
  16. The first shipment is expected to arrive
  17. some time next month.
  18. The vaccine is the second
  19. to be authorised by the
  20. Health Sciences authority
  21. and endorsed by the expert committy
  22. on Covid-19 vaccination.
  23. It has a high efficacy of 94%.
  24. This efficacy was based on a phase 3
  25. clinical trial, conducted with over 30,000
  26. participants, aged 18-95.
  27. Moderna's vaccination regime
  28. requires 2 doses to be administered,
  29. 28 days apart.
  30. Unlike the Pfizer vaccine,
  31. which is for individuals
  32. aged 16 and above,
  33. Moderna is approved for people aged 18
  34. and above.
  35. Those who shouldn't take the vaccine
  36. include pregnant women,
  37. severely immunocompromised persons,
  38. and persons with history of
  39. severe allergies.
  40. According to 1 expert,
  41. the Moderna vaccine is similar
  42. to Pfizer-BioNTech, in terms of
  43. profile and efficacy.
  44. [Deputy Director] i don't think there's any
  45. major difference between the 2
  46. if you look at the clinical trial data,
  47. the efficacy is about the same.
  48. Both are around 95%.
  49. The side effect profile is about
  50. the same.
  51. So the Moderna uses a slightly higher
  52. dose than Pfizer:
  53. 100mcg compared to 30mcg
  54. [Nisha Rahim] Though the storage conditions
  55. are different, Pfizer vaccines will need
  56. to be stored at -70°C,
  57. compared to Moderna's -20°C.
  58. That won't be an issue
  59. as Singapore has the storage capacity
  60. for both.
  61. The consideration now is whether
  62. there's enough ready supply.
  63. [Deputy Director] The bigger consideration is
  64. which vaccine is going to be available
  65. to Singapore.
  66. There will be a global shortage
  67. in production
  68. because the demand right now
  69. far out-strips the supply.
  70. So i think for Singapore's population,
  71. the more important consideration
  72. is 'do these vaccines work?'
  73. the answer is 'yes'
  74. 'are they safe?', i think the answer is
  75. 'yes'
  76. There is practically no real difference
  77. between these vaccines,
  78. so it's a question of
  79. which one can Singapore get its
  80. hand on?
  81. [Nisha Rahim] As of Tuesday,
  82. more than 175,000 individuals
  83. in Singapore have received the
  84. first dose of the Pfizer-BioNTech vaccine.
  85. About 6000 of them have also
  86. received the 2nd dose.